GENDIUS
Gendius was founded by Chris Genders and Rory Cameron with a view to making living with diabetes easier. The company has developed Intellin® - an App platform that uses an individual’s clinical history to predict those areas most likely of developing complications from their diabetes i.e. their individual high-risk areas. The platform then focusses the individual on clinically validated tasks and measures to slow their progression in these areas.
GENDIUS
Industry:
Genetics Health Care Hospital Life Science
Founded:
2011-01-01
Address:
Chester, Cheshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.gendius.co.uk
Total Employee:
1+
Status:
Active
Contact:
+44 1625 238 911
Email Addresses:
[email protected]
Total Funding:
995.75 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics LetsEncrypt Google Tag Manager Global Site Tag Nginx Euro Microsoft Exchange Online
Similar Organizations
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Momentum Fund
Momentum Fund investment in Grant - Gendius
Innovate UK
Innovate UK investment in Grant - Gendius
GM&C Life Sciences Fund
GM&C Life Sciences Fund investment in Series A - Gendius
Official Site Inspections
http://www.gendius.co.uk
- Host name: 199.59.243.228
- IP address: 199.59.243.228
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Gendius"
Gendius - Crunchbase Company Profile & Funding
Organization. Gendius . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number …See details»
Gendius Ltd - LinkedIn
Gendius.co.uk 14 3 Comments Like Comment Share Gendius Ltd 951 followers 11mo Report this post It's a privilege to be a key partner in the advancing diagnostics accelerator. ...See details»
Gendius Company Profile - Office Locations, Competitors ... - Craft
Gendius is a biotechnology company developing an app-based educational programme for people with diabetes. Its Intellin platform analyzes an individual’s clinical history, identifies their risk of …See details»
Gendius - Products, Competitors, Financials, Employees, …
Cameron’s own journey with Gendius started in 2015, following an impressive 20-year career in pharma, including a decade at AstraZeneca. “The idea for Gendius came from my co-founder …See details»
Gendius - BusinessCloud
Gendius is a health data and insights business focused on metabolic disease. We deliver award-winning projects dedicated to improving patient lives and helping to solve the challenges faced …See details»
www.gendius.co.uk
Www.gendius.co.ukSee details»
Gendius - Company Profile - Tracxn
Oct 22, 2024 Gendius - Mobile app to track and improve outcomes for patients with diabetes. Raised a total funding of $1.08M over 3 rounds from 2 investors. ... Website: gendius.co.uk; …See details»
Gendius - Funding, Financials, Valuation & Investors - Crunchbase
Gendius is a diabetes management platform helping its consumers check and level diabetes. ... Momentum Fund and Innovate UK are the most recent investors. Unlock for free . Funding …See details»
Diabetes: Innovative technology for long-term health …
Aug 18, 2020 Gendius is also in discussions with a number of NHS Clinical Commissioning Groups (CCGs) about integrating Intellin® into their existing diabetes management schemes. Dr Tom Micklewright, GP, who reviewed …See details»
Gendius - new partnership will help diabetics to manage their ...
Jul 5, 2021 The project has been made possible thanks to £250k of funding from Innovate UK. Diabetes is a complex and difficult condition to manage. Mitigating the progression of the …See details»
Gendius announces funding from Catapult Ventures to launch …
Oct 10, 2017 Alderley Park, UK – 5 th October 2017. Gendius, a digital health start-up developing a solution for patients living with diabetes to better manage their condition, today …See details»
UK start-up Gendius partners with AstraZeneca to develop …
Jun 17, 2020 UK medtech start-up Gendius has signed a ‘memorandum of understanding’ with global, science-led biopharmaceutical company AstraZeneca to develop Gendius’ leading …See details»
Gendius Company Profile: Funding, Investors & Partnerships
Oct 15, 2022 Gendius’ Intellin® platform uses artificial intelligence to actively monitor patients’ diabetes management and uses their clinical history to highlight their risk for developing …See details»
Gendius’ pre-screening CKD tech granted UK regulatory approval
Sep 5, 2023 MedTech. British health data startup Gendius has received a UKCA mark for its digital pre-screening technology, the CKD Screening Prioritizer (CSP).. The CSP, which is now …See details»
Gendius partners with AstraZeneca to develop diabetes …
Jun 17, 2020 AstraZeneca has signed a ‘memorandum of understanding’ with UK medtech start-up Gendius to develop their leading diabetes management platform (Intellin®) and support …See details»
UK regulatory approval has been granted to Gendius' pre …
Sep 5, 2023 Gendius, a British health data startup, has achieved a significant milestone with its digital pre-screening technology, the CKD Screening Prioritizer (CSP), ... approval of the CSP …See details»
Gendius CKD technology to be ‘transformative’ for ... - BioWorld
Oct 2, 2023 Following the receipt of a U.K. Conformity Assessed (UKCA) mark for its kidney function diagnostic software, the CKD Screening Prioritizer (CSP), Gendius Ltd. is hoping to …See details»
Gendius initiates GP data study to develop enhanced risk …
Feb 23, 2022 UK medtech start-up Gendius has partnered with over 60 primary care practices on a data extraction study to develop enhanced risk prediction tools for people with diabetes. …See details»
Gendius working with Astrazeneca to improve diabetes care
Jun 30, 2020 LONDON – Digital health startup Gendius Ltd. is to take a lead role in an Astrazeneca plc initiative to improve diabetes care in the Gulf states, after signing an …See details»
Gendius kicks off funding round to further grow its market-leading ...
Jun 9, 2020 Medtech start-up Gendius has kicked off its latest funding round on leading crowdfunding platform, Crowdcube. The initial Crowdcube campaign is the start of a £5.8 …See details»